Targeted therapies: Pim kinase inhibition and chemoresistance

Nature Reviews Clinical Oncology

Volumn 7, Issue 1, 2010, Pages 3-

  Aujla, Mandy ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

MYC PROTEIN; PROTEIN KINASE PIM 1; PROTEIN KINASE PIM 2; PROTEIN KINASE PIM 3; PROTEIN SERINE THREONINE KINASE; PROTEIN SERINE THREONINE KINASE INHIBITOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL CYCLE PROGRESSION; DRUG TARGETING; ENZYME INHIBITION; HUMAN; INHIBITION KINETICS; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; TUMOR GROWTH;

EID: 76949109099     PISSN: 17594774     EISSN: 17594782     Source Type: Journal    
DOI: 10.1038/nrclinonc.2009.198     Document Type: Article

References (1)

1. Mumenthaler, S. M. et al. Pharmacologic inhibition of Pim kinases alters prostate cancer cell growth and resensitizes chemoresistant cells to taxanes. Mol. Cancer Ther. 8, 2882-2893 (2009)